Last reviewed · How we verify

Zefazone — Competitive Intelligence Brief

Zefazone (CEFMETAZOLE) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: cefmetazole. Area: Metabolic.

marketed cefmetazole Insulin-degrading enzyme Metabolic Small molecule Live · refreshed every 30 min

Target snapshot

Zefazone (CEFMETAZOLE).

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Zefazone TARGET CEFMETAZOLE marketed cefmetazole Insulin-degrading enzyme 1989-01-01
Coly-Mycin S tonzonium Par Sterile Products marketed tonzonium Insulin-degrading enzyme 1962-01-01
Infuvite Adult BIOTIN Pfizer marketed Vitamin C [EPC] Insulin-degrading enzyme 1953-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (cefmetazole class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Zefazone — Competitive Intelligence Brief. https://druglandscape.com/ci/cefmetazole. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: